PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals

SOUTH PLAINFIELD, N.J., June 1, 2020 -- (Healthcare Sales & Marketing Network) -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has successfully completed the acquisition of Censa Pharmaceuticals, Inc., a biopharmaceutical company focused ... Biopharmaceuticals, Mergers & Acquisitions PTC Therapeutics, Censa Pharmaceuticals, sepiapterin, phenylketonuria
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news